Clinical Trial Update: Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety study comparing QT/QTc interval effects between Eurartesim and Riamet in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Eurartesim (piperaquine tetraphosphate; artenimol)
• Riamet (artemether-lumefantrine)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Malaria, Falciparum | Phase 1 | Status: COMPLETED